menu
    • menu

    Company profile for JB Pharma

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    JB is one of India’s leading pharmaceutical companies. An integrated, public listed organization with a focus on supplying affordable, quality products both in India and International markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    JB Pharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Cnergy IT Park, 3rd floor Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025, ...
    Telephone
    Telephone
    +91-22-2439 5200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jbpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/j-b-global/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JB Pharma Q2 PAT Up 19 % At Rs. 208 Cr
    JB Pharma Q2 PAT Up 19 % At Rs. 208 Cr

    12 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jb-pharma-q2-pat-up-19-at-rs-208-cr-18213

    INDPHARMAPOST
    12 Nov 2025
    Share Share
    JB Pharma Q1 FY26 PAT up at 14% to Rs. 202 Cr
    JB Pharma Q1 FY26 PAT up at 14% to Rs. 202 Cr

    02 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jb-pharma-q1-fy26-pat-up-at-14-to-rs-202-cr-17522

    INDPHARMAPOST
    02 Aug 2025
    Share Share
    Torrent Pharma To Acquire JB Chemicals Stake From KKR
    Torrent Pharma To Acquire JB Chemicals Stake From KKR

    30 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250629033492/en/Torrent-Pharma-to-Acquire-Controlling-Stake-in-J.-B.-Chemicals-Pharmaceuticals-from-KKR

    BUSINESSWIRE
    30 Jun 2025
    Share Share
    Novartis Offers Payment Plan for High-Cost Heart Medicine
    Novartis Offers Payment Plan for High-Cost Heart Medicine

    27 May 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-offers-payment-plan-for-high-cost-heart-medicine/articleshow/121421067.cms

    ECONOMICTIMES
    27 May 2025
    Share Share
    JB Pharma's Q4 FY25 revenue grows 10% to Rs. 949 crore
    JB Pharma's Q4 FY25 revenue grows 10% to Rs. 949 crore

    16 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jb-pharma-records-revenue-growth-of-10-to-rs-949-crore-in-q4-fy25-17156

    INDPHARMAPOST
    16 May 2025
    Share Share
    JB Pharma Q4 profit up 15% to 145.6 cr; revenue rises 10%
    JB Pharma Q4 profit up 15% to 145.6 cr; revenue rises 10%

    14 May 2025

    // BUSINESS STD

    https://www.business-standard.com/companies/quarterly-results/jb-pharma-q4fy25-profit-up-15-pc-strong-domestic-growth-leads-125051401581_1.html

    BUSINESS STD
    14 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search